CClinicalTrials.gg
CompletedNCT06041074Updated Apr 9, 2024

Adenoid Vegetations in Adult Patients

An observational study in Adenoid Vegetation, sponsored by Varazdin General Hospital. Completed at 1 site in Croatia. Open to participants aged 1 Year to 105 Years. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Varazdin General Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
161
Ages
1 Year to 105 Years
Sex
All
01

Study summary

In this observational cross-sectional study " the clinical characteristics of adenoid vegetations in adulthood will be investigated.

Read the detailed description

Adenoid vegetations typically appear in childhood and are well described in this population. However, in adulthood, adenoid vegetations appear rarely and their characteristics have not been described.

The clinical characteristics of adenoid vegetations in adulthood will be investigated, and compared with clinical characteristics of adenoid vegetations in childhood.

02

Conditions studied

  • Adenoid Vegetation
03

In context

Lead sponsor

Varazdin General Hospital is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 105 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult group: All patients aged 14 and more treated for adenoid vegetations in Varazdin General Hospital from 1 January 2013 to 31 December 2019

Children group: All patients aged 13 and less treated for adenoid vegetations in Varazdin General Hospital from 1 January 2019 to 31 December 2019

Inclusion criteria

  • patient with adenoid vegetations

Exclusion criteria

Exclusion Criteria:

  • other concomitant otorhinolaryngological diagnoses
  • hypertrophy of the tonsils
  • oropharyngeal carcinomas
  • chronic sinuitis
  • allergic rhinitis
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
161 participants (actual)
Patient registry
No

Groups and cohorts

  • Adults

    Patients with adenoid vegetations, 14 years old and older

  • Children

    Patients with adenoid vegetations, 13 years old and younger

06

What researchers measure

Primary outcomes

  1. Symptoms

    The leading symptom (patient's main complaint, the reason for seeing the doctor) will we recorded for each participant

    Time frame: 2 months

Secondary outcomes

  1. Duration of symptoms

    The duration of leading symptom (in months) will be recorded for each participant

    Time frame: 2 months

  2. OTS (otoscopic)

    The otoscopic findings will be recorded in both groups

    Time frame: 2 months

  3. RNS (rhinoscopic)

    The rhinoscopic findings will be recorded in both groups

    Time frame: 2 months

  4. OFS (oropharyngoscopic)

    The oropharyngoscopic findings will be recorded in both groups

    Time frame: 2 months

  5. PRNS (post-rhynoscopic)

    The post-rhynoscopic findings will be recorded in both groups

    Time frame: 2 months

  6. Referring physician

    The physician (primary or secondary level) who referred the patient to ENT (Ear Nose and Throat doctor) will be recorded in both groups

    Time frame: 2 months

  7. PHD ( pathohistological findings)

    The pathohistological findings will be recorded in both groups

    Time frame: 2 months

  8. Surgery

    The type of surgery will be recorded in both groups

    Time frame: 2 months

  9. Outcome

    The outcome (the relief of the leading symptom) will be recorded in both groups

    Time frame: 2 months

  10. Recurrence

    The recurrence will be recorded in both groups

    Time frame: 2 months

07

Study locations

1 site
  • Varazdin General Hospital
    Varazdin, 42000, Croatia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06041074
Lead sponsor
Varazdin General Hospital
Responsible party
Sponsor
First posted
Sep 18, 2023
Start date
Sep 15, 2023
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Apr 9, 2024

Study contacts

Drazen Shejbal
principal investigator · Varazdin General Hospital, Varazdin, Croatia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion